NeoGenomics expands digital pathology deal with Indica Labs

Go back to NeoGenomics expands digital pathology deal with Indica Labs

NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology

October 15, 2026 7:05 AM EDT

The collaboration is designed to support faster, more informed care for patients and providers

FORT MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (NASDAQ: NEO), a provider of oncology diagnostic solutions that enable precision medicine across the cancer care continuum, has expanded its partnership with Indica Labs, a global leader in AI-powered digital pathology. The collaboration is intended to scale NeoGenomics' digital pathology infrastructure and accelerate AI-driven diagnostics across its enterprise, giving healthcare providers and their patients more timely, consistent access to advanced diagnostic insight.

NeoGenomics selected... More